Clinical endocrinology with an evidence-based approach
Assessment and management of endocrine, metabolic, and clinical nutrition disorders, integrated with advanced diagnostic resources and grounded in translational research.
Conditions managed
Thyroid and parathyroid
- Hypothyroidism and hyperthyroidism
- Autoimmune thyroiditis
- Thyroid nodules and goiter
- Calcium and parathyroid hormone disorders
Diabetes and metabolism
- Type 1 and type 2 diabetes
- Insulin resistance and prediabetes
- Metabolic syndrome
- Dyslipidemia and cardiometabolic risk
Hypothalamic-pituitary-gonadal axis
- Male hypogonadism and female hypogonadism
- Evidence-based hormone replacement therapy
- Pituitary disorders
- Erectile dysfunction as a cardiometabolic biomarker
Adrenal and obesity
- Adrenal insufficiency and Cushing syndrome
- Hyperaldosteronism
- Obesity and pharmacological management
- Integrated nutritional assessment
Mitochondrial and bioenergetic health
- Chronic fatigue and metabolic dysregulation
- Mitochondrial dysfunction in endocrine disorders
- Oxidative stress and cellular aging
- Energy cofactor assessment (CoQ10, carnitine, NAD+)
HPTA axis, gut, and systemic inflammation
- Burnout syndrome and hypothalamic-pituitary-thyroid-adrenal axis dysregulation
- Increased intestinal permeability and dysbiosis
- Low-grade systemic inflammation
- Gut-brain axis and cortisol profile
Women's health and climacteric
- Climacteric and menopause
- Evidence-based female hormone replacement
- Post-menopausal bone health
- Menstrual cycle disorders and PMS
Neuroendocrinology and brain aging
- Neuroendocrine axis and cognitive function
- Genetics of neurodegeneration (HFE, CYP19A1)
- Neural plasticity and biomarkers
- Cognitive decline prevention
Fertility and growth
- Male and female fertility disorders
- Growth hormone axis (GH/IGF-1)
- Growth disorders and short stature
- Reproductive endocrine evaluation
Clinical approach
Endocrinology and clinical nutrition based on current evidence, with attention to individual metabolic context and relevant cardiometabolic factors. Assessment includes a structured history, complete physical examination, and hypothesis-driven laboratory investigation.
The therapeutic plan is discussed with the patient, incorporating clinical objectives, personal preferences, and consideration of available evidence. When appropriate, complementary diagnostic resources are used to refine metabolic and hormonal assessment.
The assessment considers the patient as an integrated biological system, identifying patterns of dysfunction, compromised axes, and underlying mechanisms that inform the individualized therapeutic plan.
Diagnostic resources
Body composition analysis
- Multi-frequency bioimpedance InBody 720
- Lean mass and visceral fat assessment
- Longitudinal monitoring of metabolic change
Metabolic assessment
- Indirect calorimetry
- Basal metabolic rate and energy expenditure
- Advanced biomarker panels
Integrated laboratory panels
- Complete hormonal profiles
- Cardiometabolic biomarkers
- Inflammatory and oxidative stress markers
Endocrine genetics
- Assessment of relevant polymorphisms
- Genetic risk in metabolic disease
- Translational research-informed